Jo Caers - Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-I³, University of Liège

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 202 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Value of Visual IMPeTUs Criteria and Metabolic Tumor Burden at Baseline [18F]FDG PET/CT in Patients with Newly Diagnosed Multiple Myeloma

Silvano Marchiori,François Cousin,Iraklis Papadopoulos,Claire Bernard,Marie Thys,Bernard De Prijck,Michelle Pirotte,Anne-Françoise Donneau,Roland Hustinx,Jo Caers,Nadia Withofs

EJNMMI research（2024）

引用0浏览0WOS引用

Single-cell Proteomics and Transcriptomics Capture Eosinophil Development and Identify the Role of IL-5 in Their Lineage Transit Amplification

Joseph Jorssen,Glenn Van Hulst, Kirena Mollers,Julien Pujol,Georgios Petrellis,Antonio P. Baptista,Sjoerd Schetters, Frederic Baron,Jo Caers,Bart N. Lambrecht,Benjamin G. Dewals,Fabrice Bureau,Christophe J. Desmet

IMMUNITYno. 7 (2024)

引用0浏览0WOS引用

[Is there a place for granulocytes transfusions in 2023 ?]

Adrien Barzin, Claire Maquet,Anaïs Devey,André Gothot, Bernard Dubois,Yves Beguin,Jo Caers,Sophie Servais

Revue medicale de Liegeno. 2 (2024): 80-87

引用0浏览0WOS引用

Chimeric Antigen Receptor T-cell Therapy for Haematological Malignancies: Insights from Fundamental and Translational Research to Bedside Practice

Céline Grégoire, Beatriz Coutinho de Oliveira, Paolo F Caimi,Jo Caers,Jan Joseph Melenhorst

British journal of haematology (2024)

引用0浏览0WOS引用

P-057 Comparative Efficacy of Cilta-Cel Vs Approved Comparator Treatments for Patients with Relapsed/Refractory Multiple Myeloma with 1–3 Prior Lines of Therapy: A Network Meta-Analysis

Roberto Mina,Abdullah Khan,Brian McClune,Noffar Bar,Jo Caers,Jeremy Larsen,João Mendes, Seina Lee, Nina Benachour,Diana Chen, Man Zhao,Carolina Lonardi,Ana Slaughter, Tamar Lengil,Heather Burnett,Allie Cichewicz, Binod Neupane,Octavio Costa Filho,Dominik Dytfeld,Surbhi Sidana

Clinical Lymphoma Myeloma and Leukemia (2024): S74

引用0浏览0引用

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS

N. van de Donk, M.C. Minnema,B. van der Holt,F. Schjesvold,K.L. Wu,A. Capra, A. Broyl,W.W.H. Roeloffzen,A.P.A. Gadisseur,G. Pietrantuono,L. Pour,V. van der Velden,T. Lund,M. Offidani,M. Grasso,L. Giaccone,M. Cavo,T. Silkjaer,J. Caers,S. Zweegman,R. Hajek, R. Benjamin,A. Vangsted, M. Boccadoro, F. Gay, P. Sonneveld, P. Musto

HemaSphere（2023）

引用0浏览0引用

Improvement of Untargeted Proteomics Workflow for Surfaceome Profiling and Its Evaluation Through the Implementation of Quality Controls: Application to Multiple Myeloma

Marie-Jia Gou, Julien Charpentier,Gael Cobraiville,Jacques Crommen,Jo Caers,Marianne Fillet

Analytica chimica acta (2023): 341764-341764

引用0浏览0WOS引用

Post-transplant Cyclophosphamide Prevents Xenogeneic Graft-Versus-host Disease While Depleting Proliferating Regulatory T Cells

Caroline Ritacco,Murat Cem Kose,Justine Courtois,Lorenzo Canti,Charline Beguin,Sophie Dubois,Benoit Vandenhove,Sophi Servais,Jo Caers,Yves Beguin,Gregory Ehx,Frederic Baron

iScience（2023）

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn